SRIDHAR BEERAM MD NPI 1275626970

NPI Details

Sridhar Beeram, MD is a hematology and oncology internal medicine in San Antonio, TX with 31 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Sridhar Beeram, MD NPI is 1275626970. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

5206 RESEARCH DR
SAN ANTONIO, TX
ZIP 78240-251
Phone: (210) 595-5300
Fax: (210) 614-8740

The NPI 1275626970 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, azacitidine, 1 mg (HCPCS:J9025)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS:Q5118)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Ferritin (blood protein) level (HCPCS:82728)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Reticulated (young) platelet measurement (HCPCS:85055)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Injection, hydrocortisone sodium succinate, up to 100 mg (HCPCS:J1720)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Blood test, clotting time (HCPCS:85610)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Ct scan of chest with contrast (HCPCS:71260)
• Protein measurement, serum (HCPCS:84165)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Drawing of blood for a medical problem (HCPCS:99195)
• Injection of drug or substance into vein (HCPCS:96374)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Ct scan of chest without contrast (HCPCS:71250)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)

The enumeration date for this NPI number is 10/2/2006 and was last updated on 2/26/2018.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.